Ex-vivo product performance of Diskus™ and Turbuhaler™ inhalers using inhalation profiles from patients with severe chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 95, Issue 5, 2001, Pages 324-330

  Burnell, P K P ^a   Small, T ^b   Doig, S ^a   Johal, B ^a   Jenkins, R ^a   Gibson, G J ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

COPD; Diskus ; Dry powder inhalers; Turbuhaler

Indexed keywords

BUDESONIDE; FLUTICASONE PROPIONATE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRY POWDER; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IN VITRO STUDY; INHALATION; INHALER; MALE; PARTICLE SIZE; POWDER INHALER; PREDICTION; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; SIMULATOR;

EID: 0034933441     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2001.1044     Document Type: Article

References (27)

1. A comparison of the inspiratory effort required to operate the Diskhaler inhaler and Turbuhaler inhaler in the administration of powder drug formulations
2. Deposition patterns of aerosolised drugs within human lungs. Effects of ventilatory parameters
3. Effect of administration technique on bronchodilator response to fenoterol in a metered dose inhaler
4. Spacing devices and metered dose inhalers in childhood asthma
5. Inhalation devices for asthma: Choosing the right one could make all the difference
6. Dry powder inhalers
7. The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers
8. How to use a Rotahaler™
9. Fenoterol powder inhaler technique in children; influence of inspiratory flow rate and breath-holding
10. Respiratory tract deposition of sodium cromoglycate is highly dependent upon technique of inhalation using the Spinhaler™
11. Inhalation rate of sodium cromoglycate determines plasma pharmacokinetics and protection against AMP-induced bronchoconstriction in asthma
12. Influence of inspiratory flow rate upon the effect of a Turbuhaler
13. Terbutaline sulphate Turbuhaler inhaler: Effect of inhaled flow rate on drug deposition and efficacy
14. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease
15. Design, manufacture, and dose consistency of the Serevent Diskus inhaler
16. Turbuhaler: A new powder inhaler for adminstration of drugs to the airways
17. The characterisation of inhalation devices by an inhalation simulator: The Electronic Lung
18. Design, validation and initial testing of the Electronic Lung
19. Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma
20. Design and analysis of cross-over trials
21. Robust tests for the equality of variances
22. A comparison of in vitro drug delivery from two multi-dose powder inhalation devices
23. A comparison of the performance of two modern multidose dry powder asthma inhalers
24. Drug delivery characteristics of Bricanyl Turbuhaler dry powder inhalers
25. Evaluation of interlot variability of the Turbuhaler
26. Comparison of peak pressure drops through powder inhalers during inspiration at maximum flow rate
27. Clinical effect of Diskus dry powder inhaler at low and high inspiratory flow rates in asthmatic children